US Senators Lay Out Concerns On FDA Digital Health Device Precertification Program

Three senators led by Democrat Elizabeth Warren of Massachusetts on 30 October asked the Food and Drug Administration to answer a series of questions about its precertification pilot program for digital devices.

MT1910_Digital Health_532828384_1200.jpg

Democratic Sens. Elizabeth Warren of Massachusetts, Patty Murray of Washington and Tina Smith of Minnesota want more details from the US Food and Drug Administration on the progress of its precertification program for digital health devices.

The senators are following up on a series of inquiries they sent to the FDA in 2018 regarding safety guardrails...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

PathAI Expands AISight Dx Label With PCCP-Guided Addition Of Roche Scanners

 

Roche’s scanners have been integrated with PathAI’s AISight Dx system. The system’s FDA-cleared PCCP allows new components to be validated and integrated without additional FDA clearance. Eric Walk, chief medical officer, hints at future biopharma companion diagnostic collaborations.

‘Serious Flaws’ In Medicare’s Proposal To Restart DME Competitive Bidding, AdvaMed Says

 

A proposed rule from Medicare would impact essential devices for many beneficiaries. AdvaMed says the rule would reduce incentives for companies to innovate and criticizes CMS for not providing the necessary information stakeholders need to fully understand the proposal’s implications.

Which Countries Have Adopted International Regulatory Alignment Documents?

 

Just ahead of its 28th meeting, the International Medical Device Regulators Forum has released a summary of the global uptake of its documents.

European Commission Review of the MDR and IVDR – Where Are We Right Now?

 

Political and regulatory pressures make revising the EU’s medtech regulations a tricky balancing act, two renowned medtech experts, Erik Vollebregt and Bassil Akra told Medtech Insight during a recent interview.

More from Policy & Regulation

PathAI Expands AISight Dx Label With PCCP-Guided Addition Of Roche Scanners

 

Roche’s scanners have been integrated with PathAI’s AISight Dx system. The system’s FDA-cleared PCCP allows new components to be validated and integrated without additional FDA clearance. Eric Walk, chief medical officer, hints at future biopharma companion diagnostic collaborations.

Small, Sleek, Ambitious: ViCentra Raises $85M To Develop Kaleido 2 Insulin Pump, Eyes US Market

 
• By 

Dutch insulin pump maker ViCentra secured $85m to scale European manufacturing, preparing for the 2026 launch of its thinner, lighter Kaleido 2 pump and push into US market. CEO Tom Arnold said the pump has more than 3,500 users in Europe and expects “tens of thousands” in the next 18 months.

‘Serious Flaws’ In Medicare’s Proposal To Restart DME Competitive Bidding, AdvaMed Says

 

A proposed rule from Medicare would impact essential devices for many beneficiaries. AdvaMed says the rule would reduce incentives for companies to innovate and criticizes CMS for not providing the necessary information stakeholders need to fully understand the proposal’s implications.